Florian Muller

Title: Florian Muller: Innovator in Cancer Treatment

Introduction

Florian Muller is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of cancer therapy through his innovative research and patented inventions. With a total of 3 patents, Muller has focused on developing compounds and methods that target specific enzymes and genes involved in cancer progression.

Latest Patents

Muller's latest patents include "Enolase inhibitors and methods of treatment therewith." This patent provides compounds that inhibit enolase enzymes, which can be crucial in cancer treatment. The compounds are designed to preferentially inhibit one isoenzyme over others, offering a targeted approach to therapy. Another significant patent is "Collateral gene inactivation biomarkers and targets for cancer therapy." This invention outlines methods for treating cancers associated with specific gene deletions, such as the ENO gene, by using inhibitors that can effectively target these genetic alterations.

Career Highlights

Throughout his career, Florian Muller has worked with prestigious institutions, including the University of Texas System and Dana-Farber Cancer Institute. His work has been instrumental in advancing the understanding of cancer biology and developing new therapeutic strategies.

Collaborations

Muller has collaborated with esteemed colleagues such as Ronald A. DePinho and Eliot Fletcher-Sananikone. These partnerships have further enriched his research and contributed to the development of innovative cancer treatments.

Conclusion

Florian Muller stands out as a dedicated inventor whose work in cancer therapy has the potential to make a significant impact on patient care. His innovative patents and collaborations reflect his commitment to advancing medical science and improving treatment options for cancer patients.